ASTRAZENECA PLC (ZEG.DE) Stock Fundamental Analysis

FRA:ZEG • GB0009895292

160.7 EUR
+0.95 (+0.59%)
Last: Feb 5, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

ZEG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. ZEG scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, ZEG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year ZEG was profitable.
  • In the past year ZEG had a positive cash flow from operations.
  • ZEG had positive earnings in each of the past 5 years.
  • In the past 5 years ZEG always reported a positive cash flow from operatings.
ZEG.DE Yearly Net Income VS EBIT VS OCF VS FCFZEG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • With a decent Return On Assets value of 8.21%, ZEG is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • With a decent Return On Equity value of 20.48%, ZEG is doing good in the industry, outperforming 65.45% of the companies in the same industry.
  • ZEG has a Return On Invested Capital of 14.42%. This is in the better half of the industry: ZEG outperforms 69.09% of its industry peers.
  • ZEG had an Average Return On Invested Capital over the past 3 years of 11.62%. This is below the industry average of 14.21%.
  • The 3 year average ROIC (11.62%) for ZEG is below the current ROIC(14.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.21%
ROE 20.48%
ROIC 14.42%
ROA(3y)5.35%
ROA(5y)4.19%
ROE(3y)13.78%
ROE(5y)12.42%
ROIC(3y)11.62%
ROIC(5y)9.52%
ZEG.DE Yearly ROA, ROE, ROICZEG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • The Profit Margin of ZEG (16.17%) is better than 65.45% of its industry peers.
  • ZEG's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 24.34%, ZEG perfoms like the industry average, outperforming 58.18% of the companies in the same industry.
  • ZEG's Operating Margin has improved in the last couple of years.
  • ZEG has a Gross Margin of 81.90%. This is amongst the best in the industry. ZEG outperforms 85.45% of its industry peers.
  • ZEG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.34%
PM (TTM) 16.17%
GM 81.9%
OM growth 3Y21.43%
OM growth 5Y8.6%
PM growth 3Y251.6%
PM growth 5Y18.9%
GM growth 3Y3.31%
GM growth 5Y0.47%
ZEG.DE Yearly Profit, Operating, Gross MarginsZEG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ZEG is still creating some value.
  • The number of shares outstanding for ZEG remains at a similar level compared to 1 year ago.
  • ZEG has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ZEG is higher compared to a year ago.
ZEG.DE Yearly Shares OutstandingZEG.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ZEG.DE Yearly Total Debt VS Total AssetsZEG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 6.18 indicates that ZEG is not in any danger for bankruptcy at the moment.
  • ZEG has a better Altman-Z score (6.18) than 83.64% of its industry peers.
  • The Debt to FCF ratio of ZEG is 3.41, which is a good value as it means it would take ZEG, 3.41 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 3.41, ZEG is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • ZEG has a Debt/Equity ratio of 0.61. This is a neutral value indicating ZEG is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.61, ZEG perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 3.41
Altman-Z 6.18
ROIC/WACC1.58
WACC9.14%
ZEG.DE Yearly LT Debt VS Equity VS FCFZEG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • ZEG has a Current Ratio of 0.88. This is a bad value and indicates that ZEG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.88, ZEG is not doing good in the industry: 83.64% of the companies in the same industry are doing better.
  • ZEG has a Quick Ratio of 0.88. This is a bad value and indicates that ZEG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.69, ZEG is not doing good in the industry: 76.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.69
ZEG.DE Yearly Current Assets VS Current LiabilitesZEG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • ZEG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.61%, which is quite impressive.
  • ZEG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.59% yearly.
  • Looking at the last year, ZEG shows a quite strong growth in Revenue. The Revenue has grown by 13.52% in the last year.
  • The Revenue has been growing by 17.27% on average over the past years. This is quite good.
EPS 1Y (TTM)20.61%
EPS 3Y15.85%
EPS 5Y18.59%
EPS Q2Q%14.42%
Revenue 1Y (TTM)13.52%
Revenue growth 3Y13.06%
Revenue growth 5Y17.27%
Sales Q2Q%11.99%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.37% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 7.20% on average over the next years.
EPS Next Y14.52%
EPS Next 2Y13.43%
EPS Next 3Y12.85%
EPS Next 5Y12.37%
Revenue Next Year10.2%
Revenue Next 2Y8.11%
Revenue Next 3Y7.34%
Revenue Next 5Y7.2%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZEG.DE Yearly Revenue VS EstimatesZEG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
ZEG.DE Yearly EPS VS EstimatesZEG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 20.90, the valuation of ZEG can be described as rather expensive.
  • The rest of the industry has a similar Price/Earnings ratio as ZEG.
  • Compared to an average S&P500 Price/Earnings ratio of 27.97, ZEG is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 18.06, the valuation of ZEG can be described as rather expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as ZEG.
  • ZEG's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.96.
Industry RankSector Rank
PE 20.9
Fwd PE 18.06
ZEG.DE Price Earnings VS Forward Price EarningsZEG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ZEG is valued a bit more expensive than 67.27% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ZEG is valued a bit more expensive than 61.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 61.84
EV/EBITDA 29.67
ZEG.DE Per share dataZEG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of ZEG may justify a higher PE ratio.
  • A more expensive valuation may be justified as ZEG's earnings are expected to grow with 12.85% in the coming years.
PEG (NY)1.44
PEG (5Y)1.12
EPS Next 2Y13.43%
EPS Next 3Y12.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.75%, ZEG has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.94, ZEG has a dividend in line with its industry peers.
  • ZEG's Dividend Yield is comparable with the S&P500 average which is at 1.79.
Industry RankSector Rank
Dividend Yield 1.75%

5.2 History

  • The dividend of ZEG has a limited annual growth rate of 1.40%.
Dividend Growth(5Y)1.4%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 52.89% of the earnings are spent on dividend by ZEG. This is a bit on the high side, but may be sustainable.
  • ZEG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP52.89%
EPS Next 2Y13.43%
EPS Next 3Y12.85%
ZEG.DE Yearly Income VS Free CF VS DividendZEG.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
ZEG.DE Dividend Payout.ZEG.DE Dividend Payout, showing the Payout Ratio.ZEG.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ASTRAZENECA PLC

FRA:ZEG (2/5/2026, 7:00:00 PM)

160.7

+0.95 (+0.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)02-10
Inst Owners49.17%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap498.26B
Revenue(TTM)58.13B
Net Income(TTM)9.40B
Analysts82.42
Price Target175.52 (9.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.75%
Yearly Dividend2.53
Dividend Growth(5Y)1.4%
DP52.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-1.74%
Max EPS beat(2)1.47%
EPS beat(4)2
Avg EPS beat(4)2.1%
Min EPS beat(4)-1.74%
Max EPS beat(4)9.32%
EPS beat(8)4
Avg EPS beat(8)0.88%
EPS beat(12)8
Avg EPS beat(12)2.53%
EPS beat(16)12
Avg EPS beat(16)3.75%
Revenue beat(2)0
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.26%
Max Revenue beat(2)-0.24%
Revenue beat(4)1
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-3.99%
Max Revenue beat(4)2.7%
Revenue beat(8)3
Avg Revenue beat(8)0.07%
Revenue beat(12)4
Avg Revenue beat(12)-0.52%
Revenue beat(16)6
Avg Revenue beat(16)0.18%
PT rev (1m)5.49%
PT rev (3m)11.92%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)-0.46%
EPS NY rev (1m)2.29%
EPS NY rev (3m)0.63%
Revenue NQ rev (1m)0.39%
Revenue NQ rev (3m)0.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.57%
Valuation
Industry RankSector Rank
PE 20.9
Fwd PE 18.06
P/S 10.18
P/FCF 61.84
P/OCF 39.08
P/B 12.89
P/tB N/A
EV/EBITDA 29.67
EPS(TTM)7.69
EY4.79%
EPS(NY)8.9
Fwd EY5.54%
FCF(TTM)2.6
FCFY1.62%
OCF(TTM)4.11
OCFY2.56%
SpS15.79
BVpS12.46
TBVpS-3.67
PEG (NY)1.44
PEG (5Y)1.12
Graham Number46.44
Profitability
Industry RankSector Rank
ROA 8.21%
ROE 20.48%
ROCE 17.6%
ROIC 14.42%
ROICexc 16.02%
ROICexgc 81.56%
OM 24.34%
PM (TTM) 16.17%
GM 81.9%
FCFM 16.46%
ROA(3y)5.35%
ROA(5y)4.19%
ROE(3y)13.78%
ROE(5y)12.42%
ROIC(3y)11.62%
ROIC(5y)9.52%
ROICexc(3y)12.66%
ROICexc(5y)10.55%
ROICexgc(3y)112.76%
ROICexgc(5y)85.06%
ROCE(3y)13.95%
ROCE(5y)11.45%
ROICexgc growth 3Y43.28%
ROICexgc growth 5Y4.77%
ROICexc growth 3Y41%
ROICexc growth 5Y11.99%
OM growth 3Y21.43%
OM growth 5Y8.6%
PM growth 3Y251.6%
PM growth 5Y18.9%
GM growth 3Y3.31%
GM growth 5Y0.47%
F-Score7
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 3.41
Debt/EBITDA 1.34
Cap/Depr 84.97%
Cap/Sales 9.59%
Interest Coverage 10.83
Cash Conversion 73.11%
Profit Quality 101.79%
Current Ratio 0.88
Quick Ratio 0.69
Altman-Z 6.18
F-Score7
WACC9.14%
ROIC/WACC1.58
Cap/Depr(3y)61.87%
Cap/Depr(5y)60.41%
Cap/Sales(3y)7.51%
Cap/Sales(5y)7.64%
Profit Quality(3y)144.6%
Profit Quality(5y)772.45%
High Growth Momentum
Growth
EPS 1Y (TTM)20.61%
EPS 3Y15.85%
EPS 5Y18.59%
EPS Q2Q%14.42%
EPS Next Y14.52%
EPS Next 2Y13.43%
EPS Next 3Y12.85%
EPS Next 5Y12.37%
Revenue 1Y (TTM)13.52%
Revenue growth 3Y13.06%
Revenue growth 5Y17.27%
Sales Q2Q%11.99%
Revenue Next Year10.2%
Revenue Next 2Y8.11%
Revenue Next 3Y7.34%
Revenue Next 5Y7.2%
EBIT growth 1Y26.07%
EBIT growth 3Y37.28%
EBIT growth 5Y27.35%
EBIT Next Year32.31%
EBIT Next 3Y16.96%
EBIT Next 5Y13.82%
FCF growth 1Y37.12%
FCF growth 3Y24.58%
FCF growth 5Y70.22%
OCF growth 1Y46.1%
OCF growth 3Y25.76%
OCF growth 5Y31.92%

ASTRAZENECA PLC / ZEG.DE FAQ

What is the fundamental rating for ZEG stock?

ChartMill assigns a fundamental rating of 5 / 10 to ZEG.DE.


What is the valuation status of ASTRAZENECA PLC (ZEG.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to ASTRAZENECA PLC (ZEG.DE). This can be considered as Overvalued.


What is the profitability of ZEG stock?

ASTRAZENECA PLC (ZEG.DE) has a profitability rating of 7 / 10.


What is the valuation of ASTRAZENECA PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ASTRAZENECA PLC (ZEG.DE) is 20.9 and the Price/Book (PB) ratio is 12.89.


Can you provide the expected EPS growth for ZEG stock?

The Earnings per Share (EPS) of ASTRAZENECA PLC (ZEG.DE) is expected to grow by 14.52% in the next year.